Abbvie M14-361, A Phase I Dose Escalation and Phase 2 Randomized Double-Blind Study of Veliparib in Combination with Carboplatin and Etoposide as a Therapy of Treatment-Naive Extensive Stage Disease Small Cell Lung Cancer

Administered By

Awarded By

Contributors

Start/End

  • September 1, 2015 - January 25, 2017